Jane Street’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Jane Street’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,803	Closed	-$306K	–	9399
2024 Q3	$306K	Buy	4,803 +374	+8%	+$24.1K	﹤0.01%	8006
2024 Q2	$262K	Buy	+4,429	New	+$245K	﹤0.01%	8001
2023 Q3	–	Sell	-6,254	Closed	-$325K	–	8639
2023 Q2	$325K	Sell	6,254 -338	-5%	-$18.6K	﹤0.01%	7001
2023 Q1	$357K	Sell	6,592 -7,780	-54%	-$439K	﹤0.01%	6899
2022 Q4	$829K	Buy	+14,372	New	+$809K	﹤0.01%	5269
2022 Q3	–	Sell	-6,002	Closed	-$290K	–	9703
2022 Q2	$290K	Buy	+6,002	New	+$305K	﹤0.01%	7662
2022 Q1	–	Sell	-6,381	Closed	-$518K	–	10285
2021 Q4	$518K	Buy	+6,381	New	+$547K	﹤0.01%	7198
2021 Q3	–	Sell	-10,765	Closed	-$1.09M	–	9925
2021 Q2	$1.06M	Buy	+10,765	New	+$939K	﹤0.01%	5703
2021 Q1	–	Sell	-2,565	Closed	-$242K	–	9082
2020 Q4	$221K	Buy	+2,565	New	+$199K	﹤0.01%	6819
2020 Q1	–	Sell	-24,327	Closed	-$1.36M	–	5309
2019 Q4	$1.5M	Buy	24,327 +8,554	+54%	+$456K	﹤0.01%	2261
2019 Q3	$671K	Buy	15,773 +10,354	+191%	+$491K	﹤0.01%	3142
2019 Q2	$281K	Sell	5,419 -12,633	-70%	-$629K	﹤0.01%	4284
2019 Q1	$1M	Buy	+18,052	New	+$973K	﹤0.01%	2807
2018 Q4	–	Sell	-12,429	Closed	-$648K	–	4941
2018 Q3	$866K	Sell	12,429 -17,789	-59%	-$1.16M	﹤0.01%	2939
2018 Q2	$1.73M	Buy	+30,218	New	+$1.65M	﹤0.01%	2111
2018 Q1	–	Sell	-4,522	Closed	-$271K	–	4803
2017 Q4	$254K	Buy	+4,522	New	+$255K	﹤0.01%	3934
2017 Q1	–	Sell	-10,417	Closed	-$484K	–	4125
2016 Q4	$416K	Sell	10,417 -3,766	-27%	-$161K	﹤0.01%	3035
2016 Q3	$687K	Sell	14,183 -13,950	-50%	-$663K	﹤0.01%	2419
2016 Q2	$1.09M	Sell	28,133 -12,191	-30%	-$526K	0.01%	1887
2016 Q1	$1.65M	Buy	40,324 +12,534	+45%	+$554K	0.01%	1363
2015 Q4	$1.99M	Buy	+27,790	New	+$1.86M	0.01%	1085
2015 Q3	–	Sell	-7,346	Closed	-$626K	–	3571
2015 Q2	$664K	Sell	7,346 -60,820	-89%	-$5.23M	﹤0.01%	1997
2015 Q1	$5.4M	Sell	68,166 -12,354	-15%	-$916K	0.04%	375
2014 Q4	$5.05M	Buy	+80,520	New	+$4.72M	0.04%	333
2014 Q3	–	Sell	-38,250	Closed	-$1.85M	–	2540
2014 Q2	$1.77M	Buy	38,250 +15,186	+66%	+$599K	0.02%	593
2014 Q1	$921K	Buy	23,064 +16,936	+276%	+$769K	0.01%	1026
2013 Q4	$231K	Buy	+6,128	New	+$205K	﹤0.01%	1899

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

CWM

Crowley Wealth Management Wilmington, Delaware $126M AUM 23.04% 1-Year Est. Return

Jane Street's BIB Position: Q4 2024 in Review

Jane Street sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2024, closing a stake of 4,803 shares — an estimated $306K sold.

Jane Street first reported a position in BIB in Q4 2013 and held it in 27 quarters. The position peaked at $5.4M in Q1 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q4 2024.

Jane Street reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2024 after selling out during the quarter.
Jane Street sold 4,803 ProShares Ultra NASDAQ Biotechnology shares in Q4 2024, an estimated $306K.
Jane Street first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2013 and held it in 27 quarters.
Jane Street's ProShares Ultra NASDAQ Biotechnology position peaked at $5.4M in Q1 2015.
24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.